Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivatrex is a medical device and biotechnology company specializing in the development of advanced synthetic bone graft substitutes for orthopedic, dental, and neurosurgical applications. The company's core technology focuses on bioactive and resorbable materials designed to provide an osteoconductive scaffold that promotes natural bone growth and integration. Their flagship product, also named Vivatrex, is engineered to be gradually replaced by the patient's own bone, offering a reliable alternative to autografts and allografts. By leveraging biomaterials science, Vivatrex aims to improve surgical outcomes and patient recovery in procedures requiring bone regeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivatrex.